ZITUVIMET XR
Generic: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
ZITUVIMET XR is FDA application NDA216778, sponsored by ZYDUS LIFESCIENCES. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Failed Moisture Limits: Out of specification for water content
Presence of Foreign Tablets/Capsules.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable i
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable i
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake lev
CGMP Deviations
Presence of Foreign Tablet: Metformin BP 1000mg was found in bottle of Metformin HCl 1000mg
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable i
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable i
CGMP Deviations